University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Pathology, Texas Children's Hospital, Houston, Texas.
Cancer Cytopathol. 2021 Nov;129(11):884-892. doi: 10.1002/cncy.22455. Epub 2021 Jun 2.
The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) provides a useful framework for the diagnosis of salivary gland fine-needle aspiration (FNA) biopsies. In this study, the MSRSGC was applied to salivary gland FNAs in pediatric patients to assess its usefulness and look at pitfalls.
The laboratory information system was queried over a 15-year period for all salivary gland FNAs in patients 18 years old or younger. Patient demographics, FNA diagnosis categorized according to the MSRSGC, and follow-up surgical pathology diagnoses were examined and correlated.
Thirty-two cases were identified, with an average age of 12 years (range, 0.6-18 years). A majority of the cases (84.4%) were from the parotid region. Twenty of 32 cases (62.5%) had follow-up resection. MSRSGC recategorization diagnoses of the 32 FNA cases were 34% benign neoplasm, 31% nonneoplastic, 16% nondiagnostic, 9% atypia of undetermined significance, 3% salivary neoplasm of uncertain malignant potential, 3% suspicious for malignancy, and 3% malignant. Overall, the sensitivity and specificity were 100% and 80%, respectively. On follow-up resection, 55% were neoplastic: pleomorphic adenomas (n = 6; 55%), pilomatricoma (n = 3; 28%), mucoepidermoid carcinoma (n = 1; 9%), schwannoma (n = 1; 9%), and myofibroma (n = 1; 9%).
The MSRSGC performed fairly well in the pediatric population with a low overall risk of malignancy (6%) and high sensitivity. Although the majority of pediatric salivary gland FNAs were benign, 55% of resected cases were positive for a neoplasm, with benign neoplasms outnumbering malignancy. Challenging entities included inflammatory conditions, like immunoglobulin G4-related sialadenitis, and skin and soft tissue lesions near the salivary gland.
米兰唾液腺细胞病理学报告系统(MSRSGC)为唾液腺细针抽吸活检(FNA)的诊断提供了一个有用的框架。在这项研究中,MSRSGC 被应用于儿科患者的唾液腺 FNA,以评估其有用性并探讨其局限性。
在 15 年的时间里,通过实验室信息系统查询了所有年龄在 18 岁以下的患者的唾液腺 FNA。检查并比较了患者的人口统计学数据、根据 MSRSGC 分类的 FNA 诊断以及随访的手术病理诊断。
共确定了 32 例病例,平均年龄为 12 岁(范围 0.6-18 岁)。大多数病例(84.4%)来自腮腺区。32 例中有 20 例(62.5%)进行了随访切除。32 例 FNA 的 MSRSGC 重新分类诊断为:34%良性肿瘤、31%非肿瘤性病变、16%非诊断性、9%意义未明的非典型性、3%唾液腺低度恶性潜能肿瘤、3%疑似恶性肿瘤和 3%恶性肿瘤。总体而言,敏感性和特异性分别为 100%和 80%。在随访切除中,55%为肿瘤:多形性腺瘤(n=6;55%)、毛母质瘤(n=3;28%)、黏液表皮样癌(n=1;9%)、施万细胞瘤(n=1;9%)和肌纤维瘤(n=1;9%)。
MSRSGC 在儿科人群中的表现相当不错,总体恶性肿瘤风险较低(6%),敏感性较高。虽然大多数儿科唾液腺 FNA 为良性,但 55%的切除病例为肿瘤阳性,良性肿瘤多于恶性肿瘤。具有挑战性的实体包括炎症性疾病,如 IgG4 相关唾液腺炎,以及靠近唾液腺的皮肤和软组织病变。